Link to this page
National Cancer Institute Thesaurus
Last uploaded:
February 23, 2024
Jump to:
| Preferred Name | Canagliflozin | |
| Synonyms |
CANAGLIFLOZIN JNJ-28431754-AAA Canagliflozin JNJ-24831754-ZAE JNJ-28431754 TA-7284 |
|
| Definitions |
A C-glucoside with a thiophene ring that is an orally available inhibitor of sodium-glucose transporter 2 (SGLT2) with antihyperglycemic activity. Canagliflozin is also able to reduce body weight and has a low risk for hypoglycemia. |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C91018 |
|
| CAS_Registry |
928672-86-0
|
|
| Chemical_Formula |
2C24H25FO5S.H2O
|
|
| code |
C91018
|
|
| Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978 |
|
| Contributing_Source |
CTRP FDA
|
|
| DEFINITION |
A C-glucoside with a thiophene ring that is an orally available inhibitor of sodium-glucose transporter 2 (SGLT2) with antihyperglycemic activity. Canagliflozin is also able to reduce body weight and has a low risk for hypoglycemia.
|
|
| Display_Name |
Canagliflozin
|
|
| FDA_UNII_Code |
0SAC974Z85
|
|
| FULL_SYN |
CANAGLIFLOZIN JNJ-28431754-AAA Canagliflozin JNJ-24831754-ZAE JNJ-28431754 TA-7284
|
|
| Has_Target | ||
| label |
Canagliflozin
|
|
| NCI_Drug_Dictionary_ID |
800676
|
|
| PDQ_Closed_Trial_Search_ID |
800676
|
|
| PDQ_Open_Trial_Search_ID |
800676
|
|
| Preferred_Name |
Canagliflozin
|
|
| prefixIRI |
Thesaurus:C91018
|
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance
|
|
| UMLS_CUI |
C2974540
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping